Results 81 to 90 of about 10,727 (204)

CJD mimics and chameleons [PDF]

open access: yes, 2017
Rapidly progressive dementia mimicking Creutzfeldt-Jakob disease (CJD) is a relatively rare presentation but a rewarding one to become familiar with, as the potential diagnoses range from the universally fatal to the completely reversible.
Mead, S, Rudge, P
core   +1 more source

Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Mimics of anti‐AK5 encephalitis are common and that misdiagnosis is often driven by non‐specific symptoms and clinically irrelevant antibody results. The absence of cognitive impairment as a major symptom, prominence of psychiatric and behavioral symptoms, isolated from serum positivity or low CSF antibody titers (< 1:100), and objective clinical ...
Jierui Wang   +5 more
wiley   +1 more source

Decoding Multiple Antibody Positivity: Lessons from Paraneoplastic Sensory Ataxia

open access: yesAnnals of Indian Academy of Neurology
Paraneoplastic neurologic syndromes are cancer-associated, immune-mediated neurologic manifestations that may involve any part of the nervous system.
S Sidharth   +8 more
doaj   +1 more source

Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease [PDF]

open access: yes, 2015
Objective: To determine the clinical features and presence in CSF of antineuronal antibodies in patients with pathologically proven autoimmune encephalitis derived from a cohort of patients with suspected Creutzfeldt-Jakob disease (CJD).
Beukelaar, J.W.K. (Janet) de   +9 more
core   +1 more source

Multiple Cranial Neuropathies After Lenvatinib–Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Multiple cranial neuropathy is a rare manifestation of immune‐related adverse events. To date, no cases have been reported during immune checkpoint blockade for metastatic renal cell carcinoma. This report describes a case of multiple cranial neuropathy that developed during lenvatinib and pembrolizumab combination therapy.
Hideyuki Minagawa   +9 more
wiley   +1 more source

Paraneoplastic cerebellar degeneration and psychosis in uterine malignancy

open access: yesArchives of Mental Health, 2017
Paraneoplastic Neurological Syndromes (PNS) are a group of rare disorders that occur in people with malignancies due to autoimmune mediated mechanisms affecting the central or peripheral nervous system.
Arul R Saravanan   +2 more
doaj  

What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review

open access: yesBMC Psychiatry, 2017
Background Patients with intracellular onconeural antibodies may present with neuro-psychiatric syndromes. We aimed to evaluate the evidence for an association between well-characterized onconeural antibodies and psychiatric symptoms in patients with and
Sverre Georg Sæther   +2 more
doaj   +1 more source

Primary intraocular B-cell lymphoma: case report [PDF]

open access: yes, 2007
Ocular non-Hodgkin's lymphoma is a rare condition that can involve the retina, the vitreous and the optic nerve. It can occur alone or can be associated with lymphoma of the central nervous system and a frequent manifestation is a posterior uveitis of ...
Belfort, Rubens Junior   +3 more
core   +2 more sources

Case Report: Anti-Yo antibody mediated paraneoplastic cerebellar degeneration in a patient with squamous cell lung carcinoma

open access: yesFrontiers in Immunology
Paraneoplastic cerebellar degeneration (PCD) is a heterogeneous group of neurologic syndromes associated with primary tumors. It is postulated that the immune system targets a tumor antigen that is also expressed endogenously in the nervous system.
Chen-Hao Yang, Yan Xu, Si-Yuan Fan
doaj   +1 more source

Stiff person syndrome and other immune-mediated movement disorders - new insights [PDF]

open access: yes, 2016
PURPOSE OF REVIEW: This review highlights the recent developments in immune-mediated movement disorders and how they reflect on clinical practice and our understanding of the underlying pathophysiological mechanisms.
Balint, B, Bhatia, KP
core   +1 more source

Home - About - Disclaimer - Privacy